Larscheid Gudrun, Schulz Tino, Herbst Hermann, Trögel Tina, Eulert Sascha, Pruß Axel, Schroeter Jan
Department of Pathology, Vivantes Klinikum Neukölln, Berlin, Germany.
University Tissue Bank, Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Transfus Med Hemother. 2021 Feb;48(1):32-38. doi: 10.1159/000513662. Epub 2021 Jan 5.
A serology testing for infectious diseases (HIV, hepatitis B and C, syphilis) is mandatory in tissue donors. In many donors postmortem blood is the only sample available. Even though serological tests and nucleic acid amplification tests (NAT) used are validated for postmortem blood, a characterization of those blood samples is not yet established. We therefore investigated the total immunoglobulin G (IgG) content in postmortem blood of tissue donors and compared it to a corresponding antemortem blood sample.
Ante- and postmortem blood samples were obtained from 100 consecutive tissue donors. The total IgG of all samples was measured using an immune-turbidometric test on the AU 480 Chemistry Analyzer (Beckman Coulter).
The mean total IgG concentration of antemortem blood samples from all 100 donors was 8.9 g/L ± 3.7 g/L (median 8.9 g/L, range 1.5 to 23.8 g/L). In 80 donors the IgG concentration in the antemortem blood sample was within the normal range with values ≥6 g/L (mean 10.0 g/L ± 3.3 g/L, median 9.3 g/L,). The total IgG concentration of the postmortem blood samples was lower with 7.2 g/L ± 3.2 g/L (median 6.7 g/L, range 0.6 to 18.2 g/L). The difference between the values of the antemortem and postmortem blood samples was 1.7 g/L ± 2.6 g/L (16.3%) (median 1.6 g/L, range -7.7 to 10.1 g/L). In 36 donors this difference was less than 10%, in 23 it was between 10 and 25%, in 33 between 26 and 50%, and in 8 over 50%. In 57 donors the total IgG in the postmortem blood sample was within the normal range with ≥6 g/L, in 53 of them also the value of the antemortem blood sample was within the normal range. No correlation for total IgG was found regarding the donor characteristics (age, sex, disease) and the sample characteristics (hemolysis, postmortem time).
Total IgG values in antemortem samples were below the lower limit of 6 g/L in 20% of the cases. Total IgG was significantly lower in the postmortem samples compared to the antemortem samples, while 57% were still above the lower limit. No correlation with the postmortem time could be found. This lowered IgG levels should be payed attention to when using postmortem blood for infectious serology testing. Additional NAT testing should be considered.
对组织捐献者进行传染病(艾滋病毒、乙型和丙型肝炎、梅毒)血清学检测是强制性的。在许多捐献者中,死后血液是唯一可用的样本。尽管所使用的血清学检测和核酸扩增检测(NAT)已针对死后血液进行了验证,但尚未对这些血液样本进行特征描述。因此,我们研究了组织捐献者死后血液中的总免疫球蛋白G(IgG)含量,并将其与相应的生前血液样本进行比较。
从100名连续的组织捐献者中获取生前和死后血液样本。使用AU 480化学分析仪(贝克曼库尔特公司)上的免疫比浊法测量所有样本的总IgG。
所有100名捐献者生前血液样本的平均总IgG浓度为8.9 g/L±3.7 g/L(中位数8.9 g/L,范围1.5至23.8 g/L)。在80名捐献者中,生前血液样本中的IgG浓度在正常范围内,值≥6 g/L(平均10.0 g/L±3.3 g/L,中位数9.3 g/L)。死后血液样本的总IgG浓度较低,为7.2 g/L±3.2 g/L(中位数6.7 g/L,范围0.6至18.2 g/L)。生前和死后血液样本值之间的差异为1.7 g/L±2.6 g/L(16.3%)(中位数1.6 g/L,范围-7.7至10.1 g/L)。在36名捐献者中,这种差异小于10%,在23名捐献者中为10%至25%,在33名捐献者中为26%至50%,在8名捐献者中超过50%。在57名捐献者中,死后血液样本中的总IgG在正常范围内,≥6 g/L,其中53名捐献者的生前血液样本值也在正常范围内。未发现总IgG与捐献者特征(年龄、性别、疾病)和样本特征(溶血、死后时间)之间存在相关性。
在20%的病例中,生前样本中的总IgG值低于6 g/L的下限。与生前样本相比,死后样本中的总IgG显著降低,而57%仍高于下限。未发现与死后时间存在相关性。在使用死后血液进行传染病血清学检测时,应注意这种降低的IgG水平。应考虑进行额外的NAT检测。